Zacks Research Has Positive Outlook for TEVA FY2025 Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a report issued on Thursday, April 3rd. Zacks Research analyst R. Department now expects that the company will post earnings of $2.48 per share for the year, up […]
